RHYGAZE

Pharmaceutical and medical preparations and products, biological medical and pharmaceutical preparations and products; pharmaceutical and biological preparations for medical use, namely nucleic acids, proteins, protein conjugates, peptides, attenuated viruses, viral vectors and vector constructions; biological tissue cultures for medical use; biological tissue cultures intended for use in the diagnosis, prevention and treatment of diseases, in particular eye diseases; biological tissue cultures intended for use in gene therapy treatments.

Scientific and technological services as well as research and design services relating thereto; quality control and authentication services; design and development of computers and software; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine; research and development services in the fields of molecular biology, biotechnology, pharmacy and medicine, in particular in the field of eye diseases; research and development services in the field of medical diagnostics, prophylaxis and therapy, in particular gene therapy; research services, namely examination and research of compounds and components intended for therapeutic or diagnostic use, in particular intended for use in relation to eye diseases; research services in the field of gene therapy; developing protocols, technical planning, advice and services in the fields of molecular biology, biotechnology and pharmacy, in particular intended for use in the field of ocular diseases and gene therapies.

Medical services; medical services, namely medical diagnosis through molecular biology, genetic engineering and biotechnology methods, in particular in the field of eye diseases; therapy services, in particular gene therapy.